Clinical trial
Use of [18F]FECNT in Positron Emission Tomography
NCT00083629 · National Institute of Mental Health (NIMH), NIH · Completed
Key facts
| NCT number | NCT00083629 |
|---|---|
| Title | Use of [18F]FECNT in Positron Emission Tomography |
| Official title | PET Whole Body Biodistribution and Test Retest Brain Imaging Studies Using a Dopamine Transporter Ligand [18F]FECNT |
| Lead sponsor | National Institute of Mental Health (NIMH), NIH |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Healthy |
| Intervention type | Procedure |
| Interventions | PET |
| Enrollment | 30 |
| Start date | May 1, 2004 |
| Completion | Sep 1, 2005 |
| First posted | May 27, 2004 |
| Last update posted | Mar 4, 2008 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: